Glioblastoma (GBM) is the most aggressive and lethal form of brain tumour.

Despite treatment, GBM recurrence is inevitable and tends to occur outside surgical margins or in locations remote to the primary tumour, highlighting the central role played by tumour infiltration in this malicious disease.

Little is known about the underlying molecular mechanisms driving GBM infiltration, but in a new study published in the journal Nature, researchers at Baylor College of Medicine working with animal models reveal a novel process by which neurons in locations remote to the primary tumour provoke expression of genes from glioblastoma that subsequently drive tumour infiltration.

“Previous studies have shown associations between the presence of GBM and increased neuronal activity in surrounding brain regions, which can promote tumour progression,” said first author Dr. Emmet Huang-Hobbs in Dr. Benjamin Deneen’s lab.

To study how neurons stimulate GBM infiltration, the researchers first determined which neuronal populations promoted glioma intrusion.

They hypothesised that callosal projection neurons (CPNs) localised in the cortical hemisphere contralateral to the primary tumour contributed to this phenomenon.

CPNs extend across the brain along the corpus callosum, a strip of white matter that connects the left and right cerebral hemispheres.

“Severing the corpus callosum eliminated the neuronal activity-dependent acceleration of GBM infiltration that was observed with the intact control, supporting that an intact corpus callosum is necessary to promote glioma progression and implicating CPNs’ long-range projections in remotely driving GBM infiltration,” Huang said.

“The findings suggest that GBMs receive neuronal inputs from a host of brain regions, implying that exposure to a diverse range of neuroactive compounds can potentially influence tumour growth. It’s now clear that tumour-neuron interactions are more widespread than previously thought,” said Deneen, professor and Dr. Russell J. and Marian K. Blattner Chair in the Department of Neurosurgery, director of the Center for Cancer Neuroscience and a member of the Dan L Duncan Comprehensive Cancer Center at Baylor. He also is the corresponding author of the work.

“In collaboration with the labs of Baylor researchers Dr. Jeffrey L. Noebels and Dr. Ganesh Rao, we found evidence suggesting that GBM and CPNs have a two-way conversation,” Huang said.

“CPNs promote tumour infiltration, and the tumour affects neuronal connections or synapses. The tumour remodels local neuronal synapses and makes direct synaptic connections, raising the possibility that it alters brain circuit activity in these regions that are distant from the primary tumour.”

Further analyses showed mechanistic details underlying these observations.

The researchers found that the infiltrating tumour population is enriched for axon guidance genes, including SEMA4F, which they identified as an essential factor for glioma progression and neuronal activity-dependent infiltration.

Interestingly, SEMA4F also promotes neuronal hyperactivity.

“Taken all together, we propose a model in which neurons prompt the expression of genes from glioma tumours that subsequently drive infiltration and their own synaptic activity,” Huang said.

“A better understanding of the two-way conversation between GBM and CPNs is an important step toward improved brain tumour treatments.”

Source: Baylor College of Medicine